GWAAIS 2022 Academic Conference Series - December 7
Inhaled and Intranasal Corticosteroids in Children: Benefits and Risks. This presentation will explore the benefits and risks of inhaled and intranasal corticosteroids in childern with asthma and allergic rhinitis.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunolgy and Greater Washington Allergy, Asthma & Immunology Society (GWAAIS). The American College of Allergy, Asthma & Immunolgy is accredited by the ACCME to provide continuing medical education for physicians.”
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following have no relevant financial relationships to disclose:
Planner - Theodore Kim, MD
Speaker - David Skoner, MD
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Attendance